Institution · Q-Pharm

Most cited papers from Q-Pharm

Q-Pharm

What are the most cited papers from Q-Pharm?

The most cited paper from Q-Pharm is "A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs" (James S. McCarthy, Silvana Sekuloski, Paul Griffin et al., 2011), with 185 citations. Next come "Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study" (158) and "A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults" (154).

Published TypeFieldAccessCitations

Showing 49 of 49 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs James S. McCarthy, Silvana Sekuloski, Paul Griffin et al. · PLoS ONE Open access	22 Aug 2011	185
2	Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study Elliott Geoffrey Playford et al. · The Lancet Infectious Diseases Open access	3 Feb 2020	158
3	A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics Open access	29 Oct 2020	154
4	A controlled human malaria infection model enabling evaluation of transmission-blocking interventions Katharine A. Collins, Claire Y. T. Wang, Matthew Adams et al. · Journal of Clinical Investigation Open access	Feb 2018	153
5	A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study James S. McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal Open access	13 Sep 2016	130
6	Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™) Germain J. P. Fernando, Julian Hickling, Cesar M. Jayashi Flores et al. · Vaccine Open access	17 May 2018	129
7	Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study James S. McCarthy, Julie Lotharius, Thomas Rückle et al. · The Lancet Infectious Diseases Open access	28 Mar 2017	129
8	Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers James S. McCarthy, Mark Baker, Peter K O'Rourke et al. · Journal of Antimicrobial Chemotherapy Open access	5 Jun 2016	106
9	A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720 James S. McCarthy, Joanne K. Marjason, Suzanne L. Elliott et al. · PLoS ONE Open access	19 Sep 2011	101
10	Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial Silvana Sekuloski, Michael R. Batzloff, Paul Griffin et al. · PLoS ONE Open access	2 Jul 2018	88
11	A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers James S. McCarthy, Thomas Rückle, Suzanne L. Elliott et al. · Antimicrobial Agents and Chemotherapy Open access	5 Nov 2019	84
12	Safety and Reproducibility of a Clinical Trial System Using Induced Blood Stage Plasmodium vivax Infection and Its Potential as a Model to Evaluate Malaria Transmission Paul Griffin, Cielo J. Pasay, Suzanne L. Elliott et al. · PLoS neglected tropical diseases Open access	8 Dec 2016	69
13	Plasmodium vivax Controlled Human Malaria Infection – Progress and Prospects Ruth Payne, Paul Griffin, James S. McCarthy et al. · Trends in Parasitology ReviewOpen access	10 Dec 2016	67
14	Ascending dose‐controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women Thomas E. Hughes, D. D. Kim, Joanne K. Marjason et al. · Obesity	20 Mar 2013	67
15	A Plasmodium vivax experimental human infection model for evaluating efficacy of interventions Katharine A. Collins, Claire Y. T. Wang, Matthew Douglas Adams et al. · Journal of Clinical Investigation Open access	11 Feb 2020	65
16	Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial D. D. Kim, Janakan Krishnarajah, Stephen Lillioja et al. · Diabetes Obesity and Metabolism	3 Mar 2015	63
17	DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum Katharine A. Collins, Thomas Rückle, Suzanne L. Elliott et al. · Antimicrobial Agents and Chemotherapy Open access	8 Mar 2019	57
18	Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer Hong Xiang, Abigael G. Chan, Ago B. Ahene et al. · mAbs Open access	2021	53
19	Qualitative study investigating the underlying motivations of healthy participants in phase I clinical trials Kerry J. Manton, Cassandra Gauld, Katherine Marie White et al. · BMJ Open Open access	2019	50
20	Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects Paul Griffin, Suzanne L. Elliott, Kenia G. Krauer et al. · Vaccine Open access	23 Oct 2017	45
21	Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development James S. McCarthy, Louise Marquart, Silvana Sekuloski et al. · Antimicrobial Agents and Chemotherapy Open access	5 Apr 2016	45
22	Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine Peter Nasveld, Joanne K. Marjason, Sonya Bennett et al. · Human Vaccines Open access	Nov 2010	41
23	A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients Miko Yamada, Dennis Michael Miller, Melinda Lowe et al. · Contemporary Clinical Trials Communications Open access	4 Aug 2021	40
24	Growth Rate of Plasmodium falciparum: Analysis of Parasite Growth Data from Malaria Volunteer Infection Studies Leesa F. Wockner, Isabell Hoffmann, Lachlan Webb et al. · The Journal of Infectious Diseases Open access	29 Oct 2019	39
25	Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum James S. McCarthy, Azrin N. Abd‐Rahman, Katharine A. Collins et al. · Antimicrobial Agents and Chemotherapy Open access	16 Nov 2020	34
26	An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1 J.L. Dutton, Wai-Ping Woo, Janin Chandra et al. · Human Vaccines & Immunotherapeutics Open access	31 Aug 2016	34
27	Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults Mark A. Pierce, Ruth D. Ellis, Laura B. Martin et al. · Vaccine Open access	5 Jan 2010	34
28	Pharmacokinetics of Macitentan in Caucasian and Japanese Subjects: The Influence of Ethnicity and Sex Shirin Bruderer, Joanne K. Marjason, Patricia N. Sidharta et al. · Pharmacology	2013	34
29	Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial Janin Chandra, Wai-Ping Woo, J.L. Dutton et al. · PLoS ONE Open access	17 Dec 2019	32
30	Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding Joseph Torresi, Peter Richmond, Leon G. Heron et al. · The Journal of Infectious Diseases	31 Aug 2017	32
31	Open-Label, Single-Dose, Parallel-Group Study in Healthy Volunteers To Determine the Drug-Drug Interaction Potential between KAE609 (Cipargamin) and Piperaquine Daniel S. Stein, Jay Prakash Jain, Michael J. Kangas et al. · Antimicrobial Agents and Chemotherapy Open access	7 Apr 2015	31
32	RVT-1401, A Novel Anti-FcRn Monoclonal Antibody, Is Well Tolerated in Healthy Subjects and Reduces Plasma IgG Following Subcutaneous or Intravenous Administration (P5.2-079) Jon W. Collins, Lori S. Jones, Michele Snyder et al. · Neurology	9 Apr 2019	30
33	Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study Joseph Torresi, Leon G. Heron, Ming Qiao et al. · Vaccine Open access	13 Aug 2015	27
34	Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial Joseph Proietto, Jaret L. Malloy, Dongliang Zhuang et al. · Diabetologia Open access	11 Jul 2018	20
35	Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Coadministered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults M. Farouk Chughlay, Karen I. Barnes, Myriam El Gaaloul et al. · Antimicrobial Agents and Chemotherapy Open access	25 Oct 2021	16
36	Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite Danielle I. Stanisic et al. · Infection and Immunity Open access	6 Jul 2016	14
37	Thymine, adenine and lipoamino acid based gene delivery systems Mariusz Skwarczyński, Zyta Maria Ziora, Daniel J. Coles et al. · Chemical Communications	2010	13
38	Fasting increases serum bilirubin levels in clinically normal, healthy males but not females: a retrospective study from phase I clinical trial participants Paul Griffin, Suzanne L. Elliott, Kerry J. Manton · Journal of Clinical Pathology	4 Mar 2014	12
39	Pharmacokinetics and Tolerability of Almorexant in Japanese and Caucasian Healthy Male Subjects Matthias Hoch, Petra Hoever, Federica Alessi et al. · Pharmacology	2011	7
40	Lipopeptides for the Fragment-Based Pharmaceutics Design Zyta Maria Ziora, Norbert Wimmer, Roger R. C. New et al. · International Journal of Organic Chemistry Open access	2012	4
41	Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity. Peter Nasveld, Joanne K. Marjason, Sonya Bennett et al. · PubMed Open access	Nov 2010	4
42	A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ) Daniel S. Stein, Jay Prakash Jain, Jason D. Lickliter et al. · Malaria Journal Open access	Sep 2014	1
43	Clinical and non-clinical exploration of Thinqure20 (a herbal composition) in treatment and prophylaxis of novel coronavirus and in other pathogens. Milind Gharpure, Hrishikesh ranganekar, Pranjali Pradeep Dhawal et al. · Research Square PreprintOpen access	2 May 2022	1
44	Elarekibep, an inhaled Anticalin protein, targets IL-4Rα locally: first-in-human randomized phase 1 trials of a novel potential therapeutic class in asthma Ingmar B. Bruns et al. · Respiratory Research Open access	19 Aug 2026	0
45	A Prospective clinical trial of RENOCHLOR (Sodium Copper Chlorophyllin complex) formulations as an add-on therapy for the Management of Chronic Renal Failure (CRF) Milind Gharpure, Nikhil Varma, Ravindra Mote et al. · Research Square PreprintOpen access	21 Jun 2022	0
46	Clinical exploration of safety and efficacy of Polyherbal oil as a topical application in Diabetic non healing wounds and ulcers compared with Betadine10% ointment Milind Gharpure, Nikhil Varma, Gopal Rao et al. · Research Square PreprintOpen access	7 Jun 2022	0
47	Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody Targeting the G Glycoprotein of Henipaviruses in Healthy Adults: A Randomised, First-in-Human Phase 1 Study Elliott Geoffrey Playford et al. · SSRN Electronic Journal PreprintOpen access	2019	0
48	414 A fitst-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and fluorescence contrast in skin cancer Miko Yamada, Dennis Michael Miller, Melinda Lowe et al. · Journal of Investigative Dermatology Open access	19 Apr 2018	0
49	Molecular methods for quantification of P. Falciparum and gametocyte detection Paul Griffin, Rebecca J. Rockett, Katharine R. Trenholme et al. · Pathology	2013	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.